| Top 50 Most Viewed Posts This Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. mightycydy: CYDY's Dr. Scott Hansen & The Gates Foundation (4729)  (15) |
| 2. Rosner: Short Interest Report As of Sat, Aug 3, '13 (4295) |
| 3. energy_wave: Presidential Election Winner 2024 (3111) |
| 4. Plotinus: If you go to Max’ LinkedIn pay some attention (2816) (12) |
| 5. Plotinus: It is definitely good news IMHO. LinkedIn (2679) (13) |
| 6. My69z: Gaudinski / GSK / VRC07-523LS: 2019 Pi on (2503) (6) |
| 7. Kgem: I picked up another 150,000 shares at .0029 (1684) (1) |
| 8. Kgem: Thank you Wrenchman --- you the man. (1571) |
| 9. Smoking901: If you can't monitor the UNVC Conglomerate board (1519) (3) |
| 10. Smoking901: Nov. 26th-2024 Effective July 2025, Pink Current (1373) (3) |
| 11. Kgem: Dr. David L. Dalton founded Health Resources, (1160) (1) |
| 12. toodles: Quote from BTW BigTimeWinner Tuesday, 06/12/18 (1113) |
| 13. Albert364: Love International Group, Inc. (LOVV) is a (1039) |
| 14. Go Green: $UNVC Big party happening here very soon. (993) (1) |
| 15. Evil Rabbit: Here's a decent list from ST. I know this person (939) (14) |
| 16. KenChowder: Great that 5000 girls and young women did not (935) (8) |
| 17. MGK_2: So, in the experiment, they took 4 monkeys (919) (14) |
| 18. KenChowder: I may not be reading the abstract right. Yes, (917) (13) |
| 19. jk1: $SNPW> Fox-ess's Global Partner, * Type in Global (914) (1) |
| 20. Figgs: Ever since I got my job as a lobbyist for Gilead (913) (6) |
| 21. KenChowder: For what it's worth, Dr. Max Lataillade is not (868) (23) |
| 22. KenChowder: Re Max Lataillade, the Gates Foundation, and (824) (13) |
| 23. ohm20: However, on this platform, it is very difficult (821) (31) |
| 24. ohm20: So we know that the recent discovery Jonah Sacha (791) (14) |
| 25. My69z: Feb. 2023 Cytodyn patent: " The present invention (780) (9) |
| 26. Ramjet: I get the sense that we are getting closer to a (778) (2) |
| 27. Plotinus: “The results from this preliminary study (772) (18) |
| 28. sean007: At 61 and 71 respectively...looks like life (758) (7) |
| 29. Ramjet: Here's what I know: The company, the intellectual (750) (14) |
| 30. Figgs: I heard we are to keep our Pestell in the (736) (5) |
| 31. Kgem: BREAKING NEWS - BREAKING NEWS - BREAKING NEWS (733) (7) |
| 32. ScottyDoggs: Nice to witness this cooperation between two of (731) (21) |
| 33. MGK_2: Wow, that is phenomenal. I'm excited that you're (717) (15) |
| 34. HouseofCards: Max Lataillade LinkedIn 40 minutes ago: I am (716) (15) |
| 35. Evil Rabbit: Solid close. Gotta be honest, wasn’t expecting (712) (15) |
| 36. KenChowder: Nice. At 27 weeks, did not see DNA in either of (705) (11) |
| 37. MGK_2: “” They could also have seen the results from (699) (6) |
| 38. mfglola: Maybe it is the Gates Foundation that is funding (698) (14) |
| 39. cardamine: What idiots...and now they'll watch LL reach its (697) (15) |
| 40. Buddyboy20: Agreed, updates and breaking news are two (693) (9) |
| 41. sean007: The essence was NEWS2 scores were good...compared (683) (1) |
| 42. Ramjet: I'm new to the board. That said, I've been Long (680) (21) |
| 43. Cycl2R: Once a drug is approved, and there are few (679) (2) |
| 44. ohm20: Lastly, the Company remains focused on the (675) (36) |
| 45. ohm20: Leronlimab - Disease List (currently 90) (updated (669) (28) |
| 46. jeff67: There is a gentleman who has been on right to try (669) |
| 47. KenChowder: Gates Foundation funding often targets health (662) (12) |
| 48. ohm20: I wonder if the down-regulation of VEGF, from (660) (13) |
| 49. MGK_2: ohm, as you know, most of us Greatly value your (658) (6) |
| 50. dfwl28: Glaucoma and the CCR5 connection. Excerpt: "The (655) (10) |
